The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports research to better understand, diagnose, treat, and ultimately prevent infectious, immunologic, and allergic diseases. These ongoing activities bring us closer to solving the health challenges facing our nation and the world.
This first edition of the Web-based NIAID Year in Review summarizes our programmatic and scientific accomplishments during fiscal year (FY) 2010 and describes how our budget is distributed by research programs and funding mechanisms. The NIAID Year in Review also illustrates how the Institute used funds received in FY 2010 through the American Recovery and Reinvestment Act in support of additional high-quality, peer-reviewed grants to advance NIAID’s strategic priorities.
In addition, we are pleased to highlight selected NIAID research areas that showed striking progress in FY 2010. The feature on HIV prevention notes extraordinary scientific accomplishments that have made feasible the prospect of slowing and ultimately ending the HIV/AIDS pandemic. Another feature describes our analysis of NIAID-supported translational research along the pipeline from fundamental laboratory studies to the development and evaluation of new and improved clinical practices, products, and tools. The feature on dengue research exemplifies a unique aspect of NIAID’s mission: the ability to mount a rapid research response to emerging or re-emerging microbial diseases that threaten the health of people worldwide.
2010 NIAID Year in Review focuses on a highly productive year in the Institute’s more than 60-year history. It also looks ahead as we build on these recent research advances and apply them to improve the health of people in the United States and around the world.
Anthony S. Fauci, M.D.DirectorNational Institute of Allergy and Infectious DiseasesNational Institutes of Health
Last Updated November 17, 2011
Last Reviewed August 17, 2011